NCT00992030 2021-08-19
R-ABVD vs ABVD-RT in Early Stage Hodgkin's Lymphoma
Fondazione Michelangelo
Phase 3 Terminated
Clinical Trials
7 trialsNCT00736320 2020-11-04
HD16
University of Cologne
Phase 3 Unknown
NCT01356680 2020-04-06
HD17 for Intermediate Stage Hodgkin Lymphoma
University of Cologne
Phase 3 Completed
NCT00784537 2018-02-08
HD0801
Fondazione Italiana Linfomi - ETS
Phase 2/3 Completed
NCT00920153 2016-09-16
Three Different Therapy Regimens in Treating Patients With Previously Untreated Hodgkin Lymphoma
French Innovative Leukemia Organisation
Phase 3 Terminated
NCT00816959 2011-07-20
Study Evaluating the Effect of R-mabHDI in Lymphocytic Predominant Hodgkin's Lymphoma
American Scitech International
Phase 3 Unknown
NCT00188149 2005-12-29
Optimization of the Primary Therapy for Patients With Hodgkin's Disease and Evaluation of PET
University Hospital Carl Gustav Carus
Phase 4 Unknown